Axsome Therapeutics (AXSM) Breaks Out — Targeting Analyst Price

Axsome Therapeutics (AXSM) has just broken out of a multi-month descending trendline, signaling renewed bullish momentum. I will buy at the open, targeting the analyst price target of $176.68 for a potential strong upside move. My stop will be set just below the prior resistance line (~$110), which should now act as support. This setup offers a favorable risk/reward, with the trendline breakout confirming renewed interest and upside potential.